A safer regimen for high-risk neuroblastoma

Pediatric Blood and Cancer

Volumn 53, Issue 1, 2009, Pages 3-6

  Felix, Carolyn A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; TENIPOSIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RISK; CHROMOSOME ANALYSIS; DNA DAMAGE; GENETIC VARIABILITY; HUMAN; LEUKEMIA; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW; ADULT; CHEMICALLY INDUCED DISORDER; CHILD; DRUG RESISTANCE; GENETICS; INCIDENCE; NOTE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VASCULAR DISEASE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; DRUG RESISTANCE, NEOPLASM; HUMANS; INCIDENCE; LEUKEMIA; NEUROBLASTOMA; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 66149120646     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22020     Document Type: Review

References (25)

1. Felix CA, Therapy-related leukemias, In: Pui C-H, editor. Childhood leukemias, 2nd edition. Cambridge UK: Cambridge University Press; 2006. pp. 774-804.
2. Felix CA. Secondary myelodysplasia/acute myeloid leukemia. In: Young NS, Gerson SL, High KA, editors. Clinical hematology, 1st edition. Philadelphia: Elsevier; 2006. pp. 374-388.
3. Kushner BH, Kramer K, Modak S, et al. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma. Pediatr Blood Cancer 2009.
4. Tucker MA, Meadows AT, Boice JD, Jr., et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987;78:459-464. (Pubitemid 17036759)
5. Curtis RE, Boice JD, Jr., Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-1751.
6. Blayney DW, Longo DL, Young RC, et al. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 1987;316: 710-714. (Pubitemid 17036476)
7. Bhatia S, Krailo MD, Chen Z, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood 2007;109:46-51. (Pubitemid 46053041)
8. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-1687.
9. Sandoval C, Pui CH, Bowman LC, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol 1993;11:1039-1045. (Pubitemid 23163342)
10. Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllo- toxins. J Clin Oncol 1999;17:569-577. (Pubitemid 29075244)
11. Le Deley MC, Leblanc T, Shamsaldin A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 2003;21:1074-1081. (Pubitemid 46594136)
12. Pinkel D. Selecting treatment for children with acute lymphoblastic leukemia [editorial; comment] [see comments]. J Clin Oncol 1996; 14:4-6.
13. Megonigal MD, Cheung NK, Rappaport EF, et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci USA 2000;97:2814-2819. (Pubitemid 30159254)
14. Raffini LJ, Slater DJ, Rappaport EF, et al. Panhandle and reverse- panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6. Proc Natl Acad Sci USA 2002;99:4568-4573. (Pubitemid 34286025)
15. Robinson BW, Cheung NK, Kolaris CP, et al. Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome. Blood 2008;111:3802-3812.
16. Wong P, Iwasaki M, Somervaille TC, et al. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 2007;21:2762-2774. (Pubitemid 350070722)
17. Teuffel O, Betts DR, Thali M, et al. Clonal expansion of a new MLL rearrangement in the absence of leukemia. Blood 2005;105:4151-4152. (Pubitemid 40656172)
18. Krishnan A, Bhatia S, Slovak ML, et al. Predictors of therapy- related leukemia and myelodysplasia following autologous transplantation for lymphoma: An assessment of risk factors. Blood 2000;95:1588-1593. (Pubitemid 30120817)
19. Bhatia S, Robison LL, Francisco L, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: Report from the Bone Marrow Transplant Survivor Study. Blood 2005;105:4215-4222. (Pubitemid 40720765)
20. Abruzzese E, Radford JE, Miller JS, et al. Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation. Blood 1999;94: 1814-1819. (Pubitemid 29411333)
21. Stone RM, Neuberg D, Soiffer R, et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994;12:2535-2542. (Pubitemid 24379636)
22. Heyn R, Khan F, Ensign LG, et al. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: An interim report. Med Pediatr Oncol 1994;23:99-106. (Pubitemid 24213322)
23. Pegram LD, Megonigal MD, Lange BJ, et al. t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5′ MONOPHOSPHATE SYNTHETASE) gene. Blood 2000;96:4360-4362.
24. Rivera GK, Pui CH, Santana VM, et al. Epipodophyllotoxins in the treatment of childhood cancer. Cancer Chemother Pharmacol 1994;34:S89-S95. (Pubitemid 24264051)
25. Stine KC, Saylors RL, Sawyer JR, et al. Secondary acute myelogenous leukemia following safe exposure to etoposide. J Clin Oncol 1997;15:1583-1586. (Pubitemid 27167396)